EGFR and squamous cell carcinoma: Daniel et al. discovered that patients with squamous carcinoma exhibiting a shifted splicing pattern toward EGFR isoform D respond to EGFR TKIs despite the absence of focal amplification or activating mutation in EGFR 22.